'Autistic' mice created – and treated

New Scientist and MyHealthNewsDaily.com reported Sept. 29; Medscape Today reported Sept. 26; and PsychCentral reported Sept. 25 on a Neuron study by Dr. Daniel Geschwind discovering that a key signaling pathway plays an important role in a common form of early-onset dementia, and may offer a potential target for treatment. Geschwind, who holds the Gordon and Virginia MacDonald Distinguished Chair in Human Genetics, is a professor of neurology and psychiatry and director of the Center for Autism Research and Treatment at the Semel Institute.